FS KKR Capital (FSK) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, FS KKR Capital (FSK) reported revenue of $398 million, down 9.3% over the same period last year. EPS came in at -$0.60, compared to $0.75 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $401.13 million, representing a surprise of -0.78%. The company delivered an EPS surprise of -195.24%, with the consensus EPS estimate being $0.63.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how FS KKR Capital performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Investment income- Fee income: $9 million versus the four-analyst average estimate of $15.41 million.Investment income- Dividend and other income: $91 million compared to the $81.05 million average estimate based on four analysts.Investment income- Paid-in-kind interest income: $53 million versus $61.66 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +23.3% change.Investment income- Interest income: $245 million compared to the $241.38 million average estimate based on three analysts.View all Key Company Metrics for FS KKR Capital here>>>Shares of FS KKR Capital have returned -5% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FS KKR Capital Corp. (FSK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks